Irbesartan Sandoz 150
Irbesartan Sandoz 150 is a medicine authorised by Swissmedic under authorisation number 59183. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 February 2010 and the authorisation is valid without a time limit. ATC code C09CA04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 59183 |
|---|---|
| Name | Irbesartan Sandoz 150 |
| Full name | Irbesartan Sandoz 150, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09CA04 |
| First authorisation | 25 February 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Irbesartan Sandoz 150, Filmtabletten | B | 25 February 2010 |
| 2 | Irbesartan Sandoz 300, Filmtabletten | B | 25 February 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 2 | 98 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 3 | 28 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 4 | 98 | Tablette(n) | C09CA04 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Irbesartan Sandoz 150 authorised in Switzerland?
Yes. Irbesartan Sandoz 150 is authorised by Swissmedic under authorisation number 59183, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Irbesartan Sandoz 150 have?
Irbesartan Sandoz 150 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Irbesartan Sandoz 150?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.